Enhancing Cushing's disease diagnosis: exploring the impact of desmopressin on ACTH gradient during BIPSS.
ACTH
Cushing’s disease
Cushing’s syndrome
bilateral inferior petrosal sinus sampling
desmopressin
ectopic ACTH syndrome
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2023
2023
Historique:
received:
17
05
2023
accepted:
11
07
2023
medline:
22
8
2023
pubmed:
21
8
2023
entrez:
21
8
2023
Statut:
epublish
Résumé
The differential diagnosis between Cushing's disease (CD) and ectopic ACTH syndrome (EAS) is complex, and bilateral inferior petrosal sinus sampling (BIPSS) is considered the gold-standard test. However, BIPSS with corticotropin-releasing hormone (CRH) stimulation is rarely available. This retrospective cohort study aimed to assess the accuracy of the inferior petrosal sinus to peripheral ACTH gradient (IPS:P) before and after desmopressin stimulation for the differential diagnosis of ACTH-dependent Cushing's syndrome (CS), applying different cutoff values. A total of 50 patients (48 with CD and 2 with EAS) who underwent BIPSS were included in this study. The sensitivity and specificity of IPS:P in BIPSS before and after desmopressin stimulation were evaluated. Various cutoff values for IPS:P were examined to determine their diagnostic accuracy. Using the traditional IPS:P cutoff, the sensitivity was 85.1% before stimulation, 89.6% after stimulation, and a combined sensitivity of 91.7%. Applying cutoff values of IPS:P >1.4 before and >2.8 after stimulation, the sensitivity was 87.2% and 89.6%, respectively, with a combined sensitivity of 91.7%. Receiver operating characteristic (ROC) curve analysis determined optimal cutoff values of 1.2 before stimulation and 1.57 after stimulation, resulting in a sensitivity of 93.6% and 93.8%, respectively, with a combined sensitivity of 97.9%. Specificity remained at 100% throughout all analyses. Among the 43 patients who responded positively to stimulation, 42 (97.7%) did so within the first three minutes, and all 43 (100%) did so within the first five minutes. None of the assessed clinical variables predicted the ACTH response to stimulation in BIPSS with statistical significance. ACTH stimulation with desmopressin during BIPSS improves the accuracy of IPS:P, making it a valuable tool for investigating ACTH-dependent Cushing's syndrome. Considering the low risk of complications, we recommend the use of desmopressin stimulation during BIPSS for the differential diagnosis of ACTH-dependent CS.
Identifiants
pubmed: 37600715
doi: 10.3389/fendo.2023.1224001
pmc: PMC10436086
doi:
Substances chimiques
Adrenocorticotropic Hormone
9002-60-2
Deamino Arginine Vasopressin
ENR1LLB0FP
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1224001Informations de copyright
Copyright © 2023 Almeida, Rodrigues, Costenaro, Scaffaro, Farenzena, Gastaldo and Czepielewski.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Clin Endocrinol Metab. 2020 Apr 1;105(4):
pubmed: 31758170
Endocrine. 2015 Mar;48(2):644-52
pubmed: 25030549
Clin Endocrinol (Oxf). 2017 Nov;87(5):515-522
pubmed: 28626863
Clin Endocrinol (Oxf). 2019 Aug;91(2):263-270
pubmed: 31094003
Clin Epidemiol. 2015 Apr 17;7:281-93
pubmed: 25945066
J Endocrinol Invest. 2000 Sep;23(8):542-4
pubmed: 11021772
Eur J Endocrinol. 2018 May;178(5):R201-R214
pubmed: 29472379
J Endocrinol Invest. 2019 Aug;42(8):997-1000
pubmed: 30635826
Front Horm Res. 2006;35:143-156
pubmed: 16809930
J Clin Endocrinol Metab. 2011 Apr;96(4):894-904
pubmed: 21474686
Lancet. 2006 May 13;367(9522):1605-17
pubmed: 16698415
Eur J Endocrinol. 2001 May;144(5):499-507
pubmed: 11331216
Eur J Endocrinol. 2013 Oct 08;169(5):715-23
pubmed: 23996696
J Thromb Haemost. 2003 Apr;1(4):682-9
pubmed: 12871401
Endocr J. 2009;56(3):469-76
pubmed: 19225213
Br J Neurosurg. 2020 Jun;34(3):253-257
pubmed: 32238018
Clin Endocrinol (Oxf). 2012 Apr;76(4):555-9
pubmed: 22017348
J Endocrinol Invest. 2022 Mar;45(3):629-637
pubmed: 34699044
Clin Endocrinol (Oxf). 2015 Jun;82(6):793-800
pubmed: 25376361
AJR Am J Roentgenol. 2006 Aug;187(2):562-70
pubmed: 16861564
Ann Lab Med. 2021 Nov 1;41(6):521-531
pubmed: 34108279
Clin Endocrinol (Oxf). 2007 Jan;66(1):136-42
pubmed: 17201813
J Neurointerv Surg. 2015 Sep;7(9):690-3
pubmed: 24996436
J Clin Endocrinol Metab. 2004 Dec;89(12):6005-9
pubmed: 15579751
J Clin Endocrinol Metab. 1991 Aug;73(2):408-13
pubmed: 1649842
J Clin Endocrinol Metab. 1997 Jan;82(1):176-81
pubmed: 8989255
J Clin Endocrinol Metab. 2019 Jun 1;104(6):2375-2384
pubmed: 30715394
Endocr Pract. 2011 Jan-Feb;17(1):33-40
pubmed: 20713347
J Clin Endocrinol Metab. 1999 May;84(5):1602-10
pubmed: 10323387
J Clin Endocrinol Metab. 2008 May;93(5):1526-40
pubmed: 18334580
J Clin Endocrinol Metab. 2003 Nov;88(11):5299-306
pubmed: 14602765
J Clin Endocrinol Metab. 1997 Jun;82(6):1780-5
pubmed: 9177382
BMC Endocr Disord. 2020 Sep 17;20(1):143
pubmed: 32943040
Rev Med Chil. 2007 Sep;135(9):1095-102
pubmed: 18064362
Endocr Connect. 2016 Jul;5(4):R12-25
pubmed: 27352844
J Clin Endocrinol Metab. 2015 Aug;100(8):2807-31
pubmed: 26222757
J Clin Endocrinol Metab. 2020 Oct 1;105(10):
pubmed: 32594169
Clin Endocrinol (Oxf). 2001 May;54(5):609-16
pubmed: 11380491
Eur J Endocrinol. 2007 Sep;157(3):271-7
pubmed: 17766708
J Clin Endocrinol Metab. 2000 Apr;85(4):1525-32
pubmed: 10770192
Endocrine. 2017 Mar;55(3):691-696
pubmed: 27435590
Clin Endocrinol (Oxf). 2013 Apr;78(4):481-8
pubmed: 23134530
Endocrine. 2019 Mar;63(3):582-591
pubmed: 30311170
J Clin Endocrinol Metab. 2002 Apr;87(4):1646-53
pubmed: 11932296
Clin Endocrinol (Oxf). 2018 Feb;88(2):251-257
pubmed: 29080355
Best Pract Res Clin Endocrinol Metab. 2020 Mar;34(2):101380
pubmed: 32165101
Pituitary. 2020 Oct;23(5):507-514
pubmed: 32451985
Endocr Pract. 1998 Nov-Dec;4(6):365-7
pubmed: 15251709
N Engl J Med. 1991 Sep 26;325(13):897-905
pubmed: 1652686
Endocrine. 2021 Sep;73(3):530-539
pubmed: 34080096
Lancet. 2015 Aug 29;386(9996):913-27
pubmed: 26004339
Arch Endocrinol Metab. 2016 Jun;60(3):267-86
pubmed: 27355856
J Clin Endocrinol Metab. 2005 Aug;90(8):4955-62
pubmed: 15914534